Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes. (2022)

First Author: Hezemans FH
Attributed to:  A new noradrenergic strategy to treat Impulsivity in Progressive Supranuclear Palsy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pcbi.1010079

PubMed Identifier: 35533200

Publication URI: http://europepmc.org/abstract/MED/35533200

Type: Journal Article/Review

Volume: 18

Parent Publication: PLoS computational biology

Issue: 5

ISSN: 1553-734X